Director Since: 2023
Tim Scannell brings over 30 years of experience delivering market-leading results from his leadership roles at Stryker Corporation (NYSE: SYK) (“Stryker”), a leading medical technology company. Mr. Scannell served as President and Chief Operating Officer of Stryker between 2018 and 2021, overseeing all of Stryker’s commercial businesses and regions globally. Prior to this role, he served as group president for Stryker’s MedSurg & Neurotechnology businesses for ten years. He currently serves as a director and non-executive chairman of the board of directors for Insulet Corporation (Nasdaq: PODD) and is a member of the board of directors of Novocure Limited (Nasdaq: NVCR). Mr. Scannell earned a bachelor’s degree in business administration and an MBA from the University of Notre Dame.
- Member of the Audit and Finance Committee